Skip to content

Women have significantly better response to HIV therapy than men

BHIVA 2007: Fewer than 1 in 3 began treatment in line with UK guidelines last year

Substantial HIV reduction persists for 2-3 weeks with single dose of PRO-140 antibody

Epidemic of cardiovascular disease in HIV patients `not on horizon`

Significant fall in transmitted drug-resistant HIV in UK; may be due to better treatment

No major metabolic differences between PI-based and NNRTI-based therapies in five-year trial

Dose modification associated with poorer response to HCV therapy in HIV/HCV coinfected patients

HIV infection doubles risk of heart attack in US patients; risk trebled in women

Resistance in archived virus dissimilar to circulating virus in patients on failing treatment